B. Riley Predicts Reduced Earnings for Denali Therapeutics
Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) – Analysts at B. Riley dropped their Q2 2025 earnings per share estimates for Denali Therapeutics in a research note issued to investors on Wednesday, March 5th. B. Riley analyst M. Mamtani now anticipates that the company will post earnings of ($0.80) per share for the quarter, down […]
Denali Therapeutics Inc. (NASDAQ:DNLI – Free Report) – Analysts at B. Riley dropped their Q2 2025 earnings per share estimates for Denali Therapeutics in a research note issued to investors on Wednesday, March 5th. B. Riley analyst M. Mamtani now anticipates that the company will post earnings of ($0.80) per share for the quarter, down […]
